128 related articles for article (PubMed ID: 1387704)
1. Ondansetron HCL (Zofran TM, Glaxo).
Frankiewicz V; Farrington E
Pediatr Nurs; 1992; 18(4):385-6. PubMed ID: 1387704
[No Abstract] [Full Text] [Related]
2. An overview of ondansetron for chemotherapy-induced nausea and emesis.
San Angel F
J Intraven Nurs; 1993; 16(2):84-9. PubMed ID: 8478782
[TBL] [Abstract][Full Text] [Related]
3. Management of chemotherapy-related nausea and vomiting using a serotonin antagonist.
Egan AP; Taggart JR; Bender CM
Oncol Nurs Forum; 1992 Jun; 19(5):791-5. PubMed ID: 1535124
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of SN-307 (ondansetron), given intravenously for the treatment of nausea and vomiting caused by anticancer drugs including cisplatin-open study].
Ikeda M; Taguchi T; Ota K; Furue H; Niitani H; Tsukagoshi S; Ariyoshi Y; Akasaka Y; Ohta J; Suminaga M
Gan To Kagaku Ryoho; 1992 Sep; 19(11):1905-14. PubMed ID: 1387776
[TBL] [Abstract][Full Text] [Related]
5. [New, in Austria registered specialty drugs. Zofran (Ondansetron, Glaxo)].
Erben M
Wien Klin Wochenschr; 1991; 103(19):594-601. PubMed ID: 1836917
[No Abstract] [Full Text] [Related]
6. Ondansetron reduces chemotherapy induced nausea and vomiting refractory to standard antiemetics.
Mitchell PL; Evans BD; Allan SG; Forgeson GV; Mak D; Neave L; Humm G; Langley G; Dickson D; Harvey VJ
N Z Med J; 1992 Mar; 105(929):73-5. PubMed ID: 1532054
[TBL] [Abstract][Full Text] [Related]
7. Patterns of nausea and vomiting in children: nursing assessment and intervention.
Hockenberry-Eaton M; Benner A
Oncol Nurs Forum; 1990; 17(4):575-84. PubMed ID: 2204886
[TBL] [Abstract][Full Text] [Related]
8. [The management of vomiting and nausea with zofran during the chemotherapy of malignant tumors].
Seliuzhitskiĭ IV; Eliseev SN; Ivanov AI
Voen Med Zh; 1994 Oct; (10):34-6. PubMed ID: 7831851
[No Abstract] [Full Text] [Related]
9. Ondansetron in the treatment of nausea and vomiting. Introduction.
Marschner N
Anticancer Drugs; 1993 Dec; 4 Suppl 2():3-7. PubMed ID: 8136513
[No Abstract] [Full Text] [Related]
10. Ondansetron, an antagonist of 5-HT3 receptors, in the treatment of antineoplastic drug-induced nausea and vomiting in children.
Matera MG; Di Tullio M; Lucarelli C; Casale F; Calabria C; Lampa E; Indolfi P; Rossi F
J Med; 1993; 24(2-3):161-70. PubMed ID: 7691978
[TBL] [Abstract][Full Text] [Related]
11. Practical points in the use of ondansetron.
Litwack K
J Post Anesth Nurs; 1994 Jun; 9(3):162-3. PubMed ID: 7799235
[TBL] [Abstract][Full Text] [Related]
12. Ondansetron and cisplatin-induced nausea and vomiting.
Hait WN
N Engl J Med; 1990 Nov; 323(21):1485-6. PubMed ID: 2146502
[No Abstract] [Full Text] [Related]
13. Zofran: first of a new class of antiemetics.
Wilson BA
Medsurg Nurs; 1994 Jun; 3(3):218-9. PubMed ID: 8055040
[No Abstract] [Full Text] [Related]
14. Odansetron.
Betcher DL; Burnham N
J Pediatr Oncol Nurs; 1991 Oct; 8(4):183-5. PubMed ID: 1834086
[No Abstract] [Full Text] [Related]
15. Ondansetron: a new entity in emesis control.
Graves T
DICP; 1990 Nov; 24(11 Suppl):S51-4. PubMed ID: 2148659
[TBL] [Abstract][Full Text] [Related]
16. [Chemically induced nausea and vomiting].
Farnault G
Soins; 1999 May; (635):21-2. PubMed ID: 10595215
[No Abstract] [Full Text] [Related]
17. [Ondansetron--a 5HT 3 receptor antagonist for the treatment of nausea and vomiting induced by cytostatics and radiotherapy].
Herrstedt J; Ersbøll J; Dombernowsky P
Ugeskr Laeger; 1991 Apr; 153(18):1292-5. PubMed ID: 1827555
[No Abstract] [Full Text] [Related]
18. Managing chemotherapy-related nausea and vomiting: the state of the art.
Wickham R
Oncol Nurs Forum; 1989; 16(4):563-74. PubMed ID: 2666957
[TBL] [Abstract][Full Text] [Related]
19. Emesis as a complication of cancer chemotherapy: pathophysiology, importance, and treatment.
Graves T
Pharmacotherapy; 1992; 12(4):337-45. PubMed ID: 1387707
[TBL] [Abstract][Full Text] [Related]
20. [The antiemetic effect and clinical evaluation of metoclopramide alone and combined with betamethasone in children with malignant tumor].
Hatae Y; Takeda T; Nakadate H; Hatayama Y; Kishino T; Ogawa Y
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3639-42. PubMed ID: 2817913
[No Abstract] [Full Text] [Related]
[Next] [New Search]
